O-2 Overall survival and long-term safety data from the NETTER-1 trial: 177-Lu-Dotatate vs. high-dose octreotide in patients with progressive midgut NETs
Titel:
O-2 Overall survival and long-term safety data from the NETTER-1 trial: 177-Lu-Dotatate vs. high-dose octreotide in patients with progressive midgut NETs
Auteur:
Strosberg, J. Caplin, M. Kunz, P. Ruszniewski, P. Bodei, L. Hendifar, A. Mittra, E. Wolin, E. Yao, J. Pavel, M. Grande Pulido, E. Van Cutsem, E. Seregni, E. Duarte, H. Gericke, G. Bartalotta, A. Demange, A. Mutevelic, S. Krenning, E.